MedKoo Cat#: 584474 | Name: 3CAI
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

3CAI is an inhibitor of Akt1 and Akt2 with anticancer activity.

Chemical Structure

3CAI
3CAI
CAS#28755-03-5

Theoretical Analysis

MedKoo Cat#: 584474

Name: 3CAI

CAS#: 28755-03-5

Chemical Formula: C10H8ClNO

Exact Mass: 193.0294

Molecular Weight: 193.63

Elemental Analysis: C, 62.03; H, 4.16; Cl, 18.31; N, 7.23; O, 8.26

Price and Availability

Size Price Availability Quantity
250mg USD 350.00 2 Weeks
500mg USD 600.00 2 Weeks
1g USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
3CAI
IUPAC/Chemical Name
2-chloro-1-(1H-indol-3-yl)-ethanone
InChi Key
LLZQFAXTCYDVTR-UHFFFAOYSA-N
InChi Code
InChI=1S/C10H8ClNO/c11-5-10(13)8-6-12-9-4-2-1-3-7(8)9/h1-4,6,12H,5H2
SMILES Code
ClCC(C1=CNC2=C1C=CC=C2)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 193.63 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Kim, D.J., Reddy, K., Kim, M.O., et al. (3-Chloroacetyl)-indole, a novel allosteric AKT inhibitor, suppresses colon cancer growth in vitro and in vivo. Cancer Prev. Res. (Phila). 4(11), 1842-1851 (2011). 2. Kim, J.-E., and Kang, T.-C. TRPC3- and ETB receptor-mediated PI3K/AKT activation induces vasogenic edema formation following status epilepticus. Brain Res. 1672, 58-64 (2017).